Susceptibility Test Powders, Antimycobacterial
Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.
OpenFDA device adverse-event casebook.
FDA Class II (moderate risk, special controls required), regulated under 21 CFR §866.1640 (Microbiology panel).
FDA MAUDE casebook
openFDA event book Susceptibility Test Powders LIGHT-BOOK · MAUDE
#703 of 1000 · 874 reports · 2021–2026
- BOOK 874 reports
- RANK #703 of 1000
- DEATH 0 death-typed
- INJ 4 injury-typed
- MALF 870 malfunction
- SPAN 2021–2026
- PEAK 2025: 533
- PHOTO Stent, Renal
Nearest event-volume peer: Stent, Renal (0 report gap)
Susceptibility Test Powders, Antimycobacterial sits #703 of 1000 among tracked device types with 874 MAUDE reports spanning 2021–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →
Malfunction reports run above the device-type norm
Susceptibility Test Powders carries 99.5% MALFUNCTION-coded reports, 34.7pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.
- DEATH 0.0% corpus 1.5% · below corpus mean (-1.5 pp)
- INJ 0.5% corpus 30.3% · below corpus mean (-29.8 pp)
- MALF 99.5% corpus 64.8% · above corpus mean (+34.7 pp)
Lead product-problem code Incorrect, Inadequate or Imprecise Result or Readings is 98% of coded problems · Lead manufacturer BECTON DICKINSON & CO. (SPARKS) accounts for 61% of manufacturer-tagged reports · Top event location is 100% of location-tagged rows .
Susceptibility Test Powders in the event-volume neighbourhood
FDA MAUDE report totals among this device type and nearest nationwide peers
- Culture Media
Culture Media, Non-Selective And Non-Differential
879 reports
- Graft
Graft, Vascular, Synthetic/Biologic Composite
878 reports
- Condylar Plat…
Condylar Plate Fixation Implant
876 reports
- Susceptibilit… (this)
Susceptibility Test Powders, Antimycobacterial
874 reports
- Stent, Renal
Stent, Renal
874 reports
- Electrocardio…
Electrocardiograph
868 reports
What this shows Susceptibility Test Powders, Antimycobacterial carries 874 MAUDE reports, ranked #703 of 1000.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Top Product Problems
Yearly Trend
Reports rose to 533 in 2025, up from an average of 104 in the two years before - a recent-year increase, not a lifetime pattern.
Related Entities for Susceptibility Test Powders, Antimycobacterial
Top Manufacturers
Event Locations
Compare BECTON DICKINSON & CO. (SPARKS) vs BECTON, DICKINSON & CO. (SPARKS) →
Nationwide devices with a comparable report-volume footprint
Susceptibility Test Powders carries zero death-typed MAUDE reports, so the peer set below compares report volume only; both axes are floored at ≥100 reports so the neighborhood stays in the advertised mass.
Similar report volume
Nearest other device types by FDA MAUDE report count (874 here).
Similar death-typed counts
Nearest other device types by death-typed report count (0 here), distinct from the volume row.
Read our methodology - how this data is sourced, computed, and verified.
Disclaimer: MAUDE figures for Susceptibility Test Powders are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.
Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Susceptibility Test Powders; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.